• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of protein analysis methods coupled with laser-microdissection to identify} subnanogram amounts of proteins in tissue microstructures.

Research Project

Project/Area Number 12470146
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionNational Institute of Neuroscience, National Center of Neurology and Psychiatry

Principal Investigator

KANEKO Kiyotoshi  National Institute of Neuroscience, Director, Division of Cortical Function Disorders, 神経研究所・疾病研究第七部, 部長 (10251513)

Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥11,000,000 (Direct Cost: ¥11,000,000)
Fiscal Year 2002: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2001: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2000: ¥8,400,000 (Direct Cost: ¥8,400,000)
Keywordslaser microdissection / scFv (single chain variable fragment) / tissue section / in situ phage screening / nanogram antigen / in situ western blot / scFV (single chain variable fragment) / scFv(single chain variable fragment) / レーザーマイクロダイセクション技術 / scFV(single chain variable fragment)
Research Abstract

We have developed three protein analysis methods coupled with laser-microdissection to identify subnanogram amounts of proteins in tissue microstructures. ( 1 ) In situ Phage Screening (ISPS). By coupling the laser-microdissection with phage display screening system, we obtained several single chain antibody variable region fragments (scFv) against human muscle proteins (major components: actin, myosin and tropomyosin α; a minor component, α-actinin 2) on microdissected frozen tissue thin sections (5,000 μm^2). The antigens were determined by immunoscreening of muscle-specific expression library, 2D western blot and MALDI-TOF-MS. (2) In situ Mass Spectrometry (ISMS). By MALDI-TOF-MS analysis of microdissected tissue microstructures, we successfully obtained fingerprinting using the same amount of tissue samples used in ISPS. (3) In situ Western Blotting (ISWB). Subnanogram amount of proteins from microdissected tissue sections were available for western blot analysis. We microdissected Pick bodies, deposits accumulated perinuclearly in neurons of patients with Pick's disease, and conducted high sensitive western blot analysis with anti-phosphorylated tau antibodies. Consequently, we observed novel Pick body-specific abnormally phosphorylated tau molecules. Tissue-specifically accumulated intracellular or extracellular deposits might be involved in the causes of various diseases. We have continued to determine the protein components in disease-specific deposits by our microdissection-coupled protein analysis methods.

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (35 results)

All Other

All Publications (35 results)

  • [Publications] Kaneko K: "A Synthetic Peptide Initiates Gerstmann-Straussler-Scheinker (GSS) Disease in Transgenic Mice. Running title : A peptide causes Gerstmann Straussler-Scheinker disease"Journal of Molecular Biology. 295. 997-1007 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Zulianello: "Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein"Journal of Virology. 74. 4351-4360 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Perrier V: "Mimicking dominant negative inhibition of prion replication through structure-based drug design"Proceedings of the National Academy of Sciences U.S.A.. 97. 6073-6078 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Korth C: "Expression of unglycosylated mutant prion protein facilitates PrP^<Sc> formation in neuroblastoma infected with different prion strains"Journal of General Virology. 81. 2555-2563 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Peretz D: "Antibodies inhibit prion propagation and clear cell cultures of prion infectivity"Nature. 412. 739-743 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Laws DD: "Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration"Proc Natl Acad Sci USA. 98. 11686-11690 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Furuta M: "Two-Dimensional Electrophoresis/Phage Panning (2D-PP) A Novel Technology for Direct Antibody Selection on 2-D Blots"J Biochem. 132. 245-251 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tanaka T: "In Situ Phage Screening. A method for identification of subnanogram tissue components in situ"J Biol Chem. 277. 30382-30387 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kaneko K: "A Synthetic Peptide Initiates Gerstmann-Straussler-Scheinker (GSS) Disease in Transgenic Mice. Running title: A peptide causes Gerstmann Straussler-Scheinker disease"Journal of Molecular Biology. 295. 997-1007 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Zulianello: "Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein"Journal of Virology. 74. 4351-4360 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Perrier V: "Mimicking dominant negative inhibition of prion replication through structure-based drug design"Proceedings of the National Academy of Sciences U.S.A.. 97. 6073-6078 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Korth C: "Expression of unglycosylated mutant prion protein facilitates PrP^<5C> formation in neuroblastoma infected with different prion strains"Journal of General Virology. 81. 2555-2563 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Peretz D: "Antibodies inhibit prion propagation and clear cell cultures of prion infectivity"Nature. 412. 739-743 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Laws DD: "Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration"Proc Natl Acad Sci USA. 132. 245-251 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Furuta M: "Two-Dimensional Electrophoresis /Phage Panning (2D-PP) A Novel Technology for Direct Antibody Selection on 2-D Blots"J Biochem. 132. 245-251 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tanaka T: "In Situ Phage Screening. A method for identification of subnanogram tissue components in situ"J Biol Chem. 277. 30382-30387 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Perrier V: "Dominant-negative inhibition of prion replication in transgenic mice"Proc Natl Acad Sci USA. 99. 13079-13084 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kaneko K: "A Synthetic Peptide Initiates Gerstmann Straussler-Scheinker (GSS) Disease in Transgenic Mice. Running title: A peptide causes Gerstmann Straussle scheinker disease"Journal of Molecular Biology. 295. 997-1007 (2000)

    • Related Report
      2002 Annual Research Report
  • [Publications] Zulianello: "Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of th prion protein"Journal of Virology. 74. 4351-4360 (2000)

    • Related Report
      2002 Annual Research Report
  • [Publications] Perrier V: "Mimicking dominant negativeinhibition of prion replication through structurebased drug design"Proceedings of the National Academy of Science U.S.A.. 97. 6073-6078 (2000)

    • Related Report
      2002 Annual Research Report
  • [Publications] Korth C: "Expression of unglycosylated mutant prion protein facilitates PrP formation in neuroblastoma infected with different prion strains"Journal of General Virology. 81. 2555-2563 (2000)

    • Related Report
      2002 Annual Research Report
  • [Publications] Peretz D: "Antibodies inhibit prion propagation and clear cell cultures of prion infectivity"Nature. 412. 739-743 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Laws DD: "Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration"Proc Natl Acad Sci USA. 98. 11868-11690 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Furuta M: "Two-Dimensional Electrophoresis/Phage Panning (2DPP) A Novel Technology for Direct Antibody Selection on 2D Blots"J Biochem. 132. 245-251 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tanaka T: "In situ phage screening ; a method for identification of subnanogram tissue components in situ"J Biol Chem. 277. 30382-30387 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] K.Kaneko: "A Synthetic Peptide Initiates Gerstmann-Straussler-Scheinker(GSS) Disease in Transgenic Mice. Running title : A peptide causes Gerstmann Straussler Scheinker disease"Journal of Molecular Biology. 295. 997-1007 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Zulianello: "Dominantnegative inhibitionof prion formation diminished by deletion mutagenesis of the prio protein"Journal of Molecular Biology. 74. 4351-4360 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] V.Perrier: "Mimicking dominant negativenhibition of prion replication through structurebased drug design"Proceedings of the National Academy of Science.U.S.A.. 97. 6073-6078 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] C.Korth: "Expression of unglycosylated mutant prion protein facilitates PrP^<Sc> formation in neuroblastoma infected with different prion strains"Journal of General Virology. 81. 2555-2563 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Peretz D: "Antibodies inhibit prion propagation and clear cell cultures of prion infectivity"Nature. 412. 739-743 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Laws DD: "Sokid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration"Proc Natl Acad Sci USA. 98. 11686-11690 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] K.Kaneko: "A Synthetic Peptide Initiates Gerstmann Straussler-Scheinker (GSS) Disease in Transgenic Mice. Running title : A peptide causes Gerstmann Straussler Scheinker disease"Journal of Molecular Biology. 295. 997-1007 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Zulianello: "Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the pric protein."Journal of Molecular Biology. 74. 4351-4360 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] V.Perrier: "Mimicking dominant negative inhibition of prion replication through structure based drug design."Proceedings of the National Academy of Science U.S.A.. 97. 6073-6078 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] C.Korth: "Expression of unglycosylated mutant prion protein facilitates PrP^<Sc> formation in neuroblastoma infected with different prion strains."Journal of General Virology. 81. 2555-2563 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi